QSS
BIOL

Quantitative Systematic Strategies’s Biolase, Inc. BIOL Stock Holding History

Quantitative Systematic Strategies’s Portfolio BIOL Stock Details BIOL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-5
Closed -$105K – 555
2015
Q2 		$105K Buy
+5
New +$122K 0.02% 490

Other funds holding BIOL

OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
PCMI
Princeton Capital Management Inc Princeton, New Jersey $198M AUM 28.98% 1-Year Est. Return

Quantitative Systematic Strategies's BIOL Position: Q3 2015 in Review

Quantitative Systematic Strategies sold out of Biolase, Inc. (BIOL) in Q3 2015, closing a stake of 5 shares — an estimated $105K sold.

Quantitative Systematic Strategies first reported a position in BIOL in Q2 2015 and held it in 1 quarter. The position peaked at $105K in Q2 2015. 32 funds tracked by Wall St. Rank hold BIOL as of Q3 2015.

  • Quantitative Systematic Strategies reported no remaining Biolase, Inc. position as of Q3 2015 after selling out during the quarter.
  • Quantitative Systematic Strategies sold 5 Biolase, Inc. shares in Q3 2015, an estimated $105K.
  • Quantitative Systematic Strategies first reported a position in Biolase, Inc. in Q2 2015 and held it in 1 quarter.
  • Quantitative Systematic Strategies's Biolase, Inc. position peaked at $105K in Q2 2015.
  • 32 funds tracked by Wall St. Rank held Biolase, Inc. as of Q3 2015.

Based on Quantitative Systematic Strategies's 13F filing for Q3 2015, filed 30 Oct 2015.